Cargando…

Temporal Dynamics of Anti–Type 1 Interferon Autoantibodies in Patients With Coronavirus Disease 2019

Binding levels and neutralization activity of anti–type 1 interferon autoantibodies peaked during acute coronavirus disease 2019 and markedly decreased thereafter. Most patients maintained some ability to neutralize type 1 interferon into convalescence despite lower levels of binding immunoglobulin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shaw, Elana R, Rosen, Lindsey B, Cheng, Aristine, Dobbs, Kerry, Delmonte, Ottavia M, Ferré, Elise M N, Schmitt, Monica M, Imberti, Luisa, Quaresima, Virginia, Lionakis, Michail S, Notarangelo, Luigi D, Holland, Steven M, Su, Helen C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8689695/ https://www.ncbi.nlm.nih.gov/pubmed/34875033 http://dx.doi.org/10.1093/cid/ciab1002

Ejemplares similares

SARS-CoV-2 Spike Protein-Directed Monoclonal Antibodies May Ameliorate COVID-19 Complications in APECED Patients
por: Ferré, Elise M. N., et al.
Publicado: (2021)

Autoantibodies to Interferons in Infectious Diseases
por: Quiros-Roldan, Eugenia, et al.
Publicado: (2023)

Sex differences in a cohort of COVID-19 Italian patients hospitalized during the first and second pandemic waves
por: Quaresima, Virginia, et al.
Publicado: (2021)

Correction to: Sex differences in a cohort of COVID-19 Italian patients hospitalized during the first and second pandemic waves
por: Quaresima, Virginia, et al.
Publicado: (2021)

Comment on 'AIRE-deficient patients harbor unique high-affinity disease-ameliorating autoantibodies'
por: Landegren, Nils, et al.
Publicado: (2019)

Antibody responses to the SARS-CoV-2 vaccine in individuals with various inborn errors of immunity
por: Delmonte, Ottavia M., et al.
Publicado: (2021)

Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy
por: Ferré, Elise M. N., et al.
Publicado: (2021)

High-throughput identification of autoantibodies that target the human exoproteome
por: Wang, Eric Y., et al.
Publicado: (2022)

Prognostic Value of Serum/Plasma Neurofilament Light Chain for COVID-19 Associated Mortality
por: Masvekar, Ruturaj R., et al.
Publicado: (2022)

Prognostic value of serum/plasma neurofilament light chain for COVID‐19‐associated mortality
por: Masvekar, Ruturaj R., et al.
Publicado: (2022)

Autoantibody discovery across monogenic, acquired, and COVID19-associated autoimmunity with scalable PhIP-Seq
por: Vazquez, Sara E, et al.
Publicado: (2022)

Autoimmune Regulator Deficiency Results in a Decrease in STAT1 Levels in Human Monocytes
por: Zimmerman, Ofer, et al.
Publicado: (2017)

Bortezomib treatment for refractory nontuberculous mycobacterial infection in the setting of interferon gamma autoantibodies
por: Rocco, Joseph M., et al.
Publicado: (2021)

An AIREless Breath: Pneumonitis Caused by Impaired Central Immune Tolerance
por: Ferré, Elise M. N., et al.
Publicado: (2021)

Longitudinal Serological Response to Sars-COV-2 in Patients Affected By Hematologic Diseases
por: Cattaneo, Chiara, et al.
Publicado: (2020)

High frequency of type I interferon auto‐antibodies in a group of middle‐aged HIV‐infected patients: A cross‐sectional exploratory study
por: Imberti, Luisa, et al.
Publicado: (2023)

Autoantibody discovery across monogenic, acquired, and COVID-19-associated autoimmunity with scalable PhIP-seq
por: Vazquez, Sara E, et al.
Publicado: (2022)

Impaired Sars-Cov-2 Specific Antibody Responses in Patients Treated with Anti-CD20 Antibodies
por: Sottini, Alessandra, et al.
Publicado: (2020)

Varicella-zoster virus Neurovasculitis (VZV-NV) in the Setting of Autoantibodies to Interferon alpha (anti-IFNα)
por: Ansari, Rahila, et al.
Publicado: (2017)

Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosis
por: Salvator, Hélène, et al.
Publicado: (2022)

450. Type I Interferon Autoantibodies Are Detected in Those with Critical COVID-19, Including a Young Female Patient
por: Yee, Debra, et al.
Publicado: (2021)

Serological responses to human virome define clinical outcomes of Italian patients infected with SARS-CoV-2
por: Wang, Limin, et al.
Publicado: (2022)

Granulomatous inflammation in inborn errors of immunity
por: Sacco, Keith A., et al.
Publicado: (2023)

Transient autoantibodies to danger signals
por: Shaw, Elana R., et al.
Publicado: (2023)

Autoantibodies Against Proteins Previously Associated With Autoimmunity in Adult and Pediatric Patients With COVID-19 and Children With MIS-C
por: Burbelo, Peter D., et al.
Publicado: (2022)

Clinical features of Sjögren’s syndrome patients with autoantibodies against interferons
por: Burbelo, Peter D., et al.
Publicado: (2019)

Autoantibody repertoire characterization provides insight into the pathogenesis of monogenic and polygenic autoimmune diseases
por: Clarke, Thomas, et al.
Publicado: (2023)

Hematopoietic Stem Cell Transplantation in Primary Immunodeficiency Diseases: Current Status and Future Perspectives
por: Castagnoli, Riccardo, et al.
Publicado: (2019)

Inborn Errors of Immunity With Immune Dysregulation: From Bench to Bedside
por: Delmonte, Ottavia Maria, et al.
Publicado: (2019)

Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19
por: Liu, Can, et al.
Publicado: (2021)

Mycophenolate-Induced Colitis in Autoimmune Polyendocrinopathy-Candidiasis-Ectodermal Dystrophy Patients
por: Schmitt, Monica M., et al.
Publicado: (2021)

1360. Disseminated Mycobacterium abscessus Infections in Patients with Neutralizing Anti-interferon-gamma Autoantibodies Treated with Rifabutin-based Combination Regimens
por: Cheng, Aristine, et al.
Publicado: (2019)

Case report: Discovery of a de novo FAM111B pathogenic variant in a patient with an APECED-like clinical phenotype
por: Ferré, Elise M. N., et al.
Publicado: (2023)

Preexisting autoantibodies to type I IFNs underlie critical COVID-19 pneumonia in patients with APS-1
por: Bastard, Paul, et al.
Publicado: (2021)

Autoantibodies against type I IFNs in patients with life-threatening COVID-19
por: Bastard, Paul, et al.
Publicado: (2020)

Autoantibodies to Granulocyte-Macrophage Colony-Stimulating Factor Associated With Severe and Unusual Manifestations of Cryptococcus gattii Infections
por: Crum-Cianflone, Nancy F, et al.
Publicado: (2017)

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta‐1b in MIRACLE clinical trial
por: Alotaibi, Faizah, et al.
Publicado: (2023)

Gut Microbiota–Host Interactions in Inborn Errors of Immunity
por: Castagnoli, Riccardo, et al.
Publicado: (2021)

Serological Responses to Human Virome Define Clinical Outcomes of Italian Patients Infected with SARS-CoV-2
por: Wang, Limin, et al.
Publicado: (2020)

Management of Posterior Reversible Syndrome in Preeclamptic Women
por: Poma, S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ge9djlh2pjjc938gv6f9fat2ps